Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE: Rabeprazole for Ulcer Prevention in Aspirin Users
NCT01051388Phase 3Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of rabeprazole in gastric ulcer and duodenal ulcer (3 arms), sponsored by Translational Research Center for Medical Innovation. Primary endpoint: Endoscopic Recurrence of Gastric and/or Duodenal Ulcers at 12 weeks. Started Aug 2008; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT01051388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051388.